Cigna sinks on investor worries about Trump drug rebate rule change

Cigna CEO David Cordani doesn’t see the Trump administration’s new proposal to cut Medicare pharmacy benefit rebates as a threat to its growth, as it embarks on integrating its newly acquired PBM firm Express Scripts.


Source link

Leave a Comment

Exclusive: Top U.S. insurer to cover Amgen, Eli Lilly migraine drugs, exclude TevaDry January: Does it lead to binge-drinking in February?